Shanghai Rendu Biotechnology Co., Ltd. develops molecular diagnostic tests. It mainly focuses on RNA molecular diagnostic technology and products. It engages in research & development, production and sales of molecular diagnostic reagents and equipment integrated products. The company is committed to the development and promotion of RNA based on real-time fluorescent constant temperature amplification detection technology (SAT technology for short) molecular diagnostic products. Shanghai Rendu Biotechnology was founded on June 13, 2007 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company